Skip to main content
SpringerLink
Log in

Somatostatin Receptor Gene Family - Subtype Selectivity for Ligand Binding

  • Chapter
Book cover Somatostatin

Part of the book series: Endocrine Updates ((ENDO,volume 24))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aguila, M.C., Dees, W.L., Haensly, W.E. & McCann, S.M. (1991). Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc.Natl.Acad.Sci.U.S.A. 88, 11485–11489.

    CAS  PubMed  Google Scholar 

  2. Ankersen, M., Crider, M., Liu, S., Ho, B., Andersen, H.S. & Stidsen, C. (1998). Discovery of a Novel Non-Peptide Somatostatin Agonist with SST4 Selectivity. J.Am.Chem.Soc. 120, 1368–1373.

    Article  CAS  Google Scholar 

  3. Bass, R.T., Buckwalter, B.L., Patel, B.P., Pausch, M.H., Price, L.A., Strnad, J. & Hadcock, J.R. (1996). Identification and characterization of novel somatostatin antagonists. Mol.Pharmacol. 50,709–715.

    CAS  PubMed  Google Scholar 

  4. Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T.J. & Pless, J. (1982). SMS 201-995: a very potent and selective octapeptide analog of somatostatin with prolonged action. Life Sci. 31, 1133–1140.

    Article  CAS  PubMed  Google Scholar 

  5. Baumbach, W.R., Carrick, T.A., Pausch, M.H., Bingham, B., Carmignac, D., Robinson, I.C.A.F., Houghten, R., Eppler, C.M., Price, L.A. & Zysk, J.R. (1998). A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. Mol.Pharmacol. 54, 864–873.

    CAS  PubMed  Google Scholar 

  6. Baumeister, H., Kreuzer, O.J., Roosterman, D., Schafer, J. & Meyerhof, W. (1998). Cloning, expression, pharmacology and tissue distribution of the mouse somatostatin receptor subtype 5. J.Neuroendocrinol. 10, 283–290.

    Article  CAS  PubMed  Google Scholar 

  7. Bell, G.I. & Reisine, T. (1993). Molecular biology of somatostatin receptors. Trends Neurosci. 16, 34–38.

    Article  CAS  PubMed  Google Scholar 

  8. Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J. & Guillemin, R. (1973). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179,77–79.

    CAS  PubMed  Google Scholar 

  9. Bruno, J.F., Xu, Y., Song, J. & Berelowitz, M. (1992). Molecular cloning and functional expression of a brain-specific somatostatin receptor. Proc.Natl.Acad.Sci.U.S.A. 89, 11151–11155.

    CAS  PubMed  Google Scholar 

  10. Brans, C., Lewis, L., Briner, U., Meno-Tetang, G. & Weckbecker, G. SOM230: a novel somatostatin peptidomimetic with a broad somatotropin release inhibiting factor (SST) receptor binding and a unique antisecretory profile. Eur. J. Endocrinol. 146, 707–716 (2002).

    Google Scholar 

  11. Bruns, C., Raulf, F., Hoyer, D., Schloos, J., Luebbert, H. & Weckbecker, G. (1996). Binding properties of somatostatin receptor subtypes. Metab., Clin.Exp. 44, 17–20.

    CAS  Google Scholar 

  12. Bruns, C., Shi, V., Hoyer, D., Schuurman, H. & Weckbecker, G. (2000). Somatostatin receptors and the potential use of Sandostatin to interfere with vascular remodelling. Eur.J.Endocrinol. 143, S3–S7.

    Article  CAS  PubMed  Google Scholar 

  13. Buscail, L., Delesque, N., Esteve, J.P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, P., Bell, G.I. & Liebow, C. (1994). Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogs: mediation by human somatostatin receptor subtypes SSTR1 andSSTR2. Proc.Natl.Acad.Sci.U.S.A. 91, 2315–2319.

    CAS  PubMed  Google Scholar 

  14. Buscail, L., Saint-Laurent, N., Chastre, E., Vaillant, J.C., Gespach, C., Capella, G., Kalthoff, H., Lluix, F., Vaysse, N. & Susini, C. (1996). Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res. 56, 1823–1827.

    CAS  PubMed  Google Scholar 

  15. Caron, P., Buscail, L., Beckers, A., Esteve, J.P., Igout, A., Hennen, G. & Susini, C. (1997). Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J.Clin.Endocrinol.Metab. 82 3771–3776.

    CAS  PubMed  Google Scholar 

  16. Carruthers, A.M., Warner, A.J., Michel, A.D., Feniuk, W. & Humphrey, P.P.A. (1999). Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of G.alpha.s proteins. Br.J.Pharmacol. 126, 1221–1229.

    Article  CAS  PubMed  Google Scholar 

  17. Chisholm, C. & Greenberg, G.R. (2000). Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures. Am.J.Physiol. 279, G983–G989.

    CAS  Google Scholar 

  18. Chowers, Y., Cahalon, L., ahav, M., Schor, H., Tal, R., Bar-Meir, S. & Levite, M. (2000). Somatostatin through its specific receptor inhibits spontaneous and TNF-.alpha.-and bacteria-induced IL-8 and IL-l.beta. secretion from intestinal epithelial cells. J.Immunol. 165, 2955–2961.

    CAS  PubMed  Google Scholar 

  19. Christopoulos, G., Perry, K.J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N.J., Main, M.J., Foord, S.M. & Sexton, P.M. (1999). Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol.Pharmacol. 56, 235–242.

    CAS  PubMed  Google Scholar 

  20. Corness, J.D., Demchyshyn, L.L., Seeman, P., Van Tol, H.H.M., Srikant, C.B., Kent, G., Patel, Y.C. & Niznik, H.B. (1993). A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides. FEBS Lett. 321,279–284.

    Article  CAS  PubMed  Google Scholar 

  21. Coy, D.H. & Taylor, J.E. (1996). Receptor-specific somatostatin analogs: correlations with biological activity. Metab. Clin.Exp. 44, 21–23.

    CAS  Google Scholar 

  22. Coy, D.H. & Taylor, J.E. (1999). Development of somatostatin agonists with high affinity and specificity for the human and rat type 5 receptor subtype. Pept.Proc.Am.Pept.Symp., 15, 559–560.

    Google Scholar 

  23. Curtis, S.B., Chen, J.C., Winkelaar, G., Turnbull, R.G., Hewitt, J., Buchan, A.M. & Hsiang, Y.N. (2000a). Effect of endothelial and adventitial injury on somatostatin receptor expression. Surgery 127, 577–583.

    Article  CAS  PubMed  Google Scholar 

  24. Curtis, S.B., Hewitt, J., Yakubovitz, S., Anzarut, A., Hsiang, Y.N. & Buchan, A.M.J. (2000b). Somatostatin receptor subtype expression and function in human vascular tissue. Am.J.Physiol. 278, H1815–H1822.

    CAS  Google Scholar 

  25. Dalm, V.A., van Hagen, M., van Koetsveld, P.M., Langerak, A.W., van der Lely, A.-J., Lamberts, S.W. & Hofland, L.J. Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system. J. Clin. Endocrinol. Metab. 88, 270–276 (2003).

    Article  CAS  PubMed  Google Scholar 

  26. Dasgupta, P., Singh, A.T. & Mukherjee, R. (2000). Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its anti-proliferative activity on human oral carcinoma cells in vitro. Life Sci. 66, 1557–1570.

    Article  CAS  PubMed  Google Scholar 

  27. De Lecea, L., Criado, J.R., Prospero-Garcia, O., Gautvik, K.M., Schweitzer, P., Danielson, P.E., Dunlop, C.L., Siggins, G.R., Henriksen, S.J. & Sutcliffe, J.G. (1996). A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381, 242–245.

    PubMed  Google Scholar 

  28. Delesque, N., Buscail, L., Esteve, J.P., Saint-Laurent, N., Mueller, C., Weckbecker, G., Bruns, C., Vaysse, N. & Susini, C. (1997). SST2 Somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res. 57, 956–962.

    CAS  PubMed  Google Scholar 

  29. Demchyshyn, L.L., Srikant, C.B., Sunahara, R.K., Kent, G., Seeman, P., Van Tol, H.H.M., Panetta, R., Patel, Y.C. & Niznik, H.B. (1993). Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20. Mol.Pharmacol. 43, 894–901.

    CAS  PubMed  Google Scholar 

  30. Epelbaum, J. (1986). Somatostatin in the central nervous system: physiology and pathological modifications. Prog.Neurobiol. (Oxford) 27, 63–100.

    CAS  Google Scholar 

  31. Epelbaum, J., Dournaud, P., Fodor, M. & Viollet, C. (1994). The neurobiology of somatostatin. Crit.Rev.Neurobiol. 8, 25–44.

    CAS  PubMed  Google Scholar 

  32. Fehlmann, D., Langenegger, D., Schuepbach, E., Siehler, S., Feuerbach, D. & Hoyer, D. (2000). Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery. J.Physiol. (Paris) 94, 265–281.

    CAS  Google Scholar 

  33. Feniuk, W., Dimech, J. & Humphrey, P.P.A. (1993). Characterization of somatostatin receptors in guinea pig isolated ileum, vas deferens and right atrium. Br.J.Phartnacol. 110, 1156–1164.

    CAS  Google Scholar 

  34. Feniuk, W., Jarvie, E., Luo, J. & Humphrey, P P.A. (2000). Selective somatostatin sst2 receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology 39, 1443–1450.

    Article  CAS  PubMed  Google Scholar 

  35. Feuerbach, D., Fehlmann, D., Nunn, C., Siehler, S., Langenegger, D., Bouhelal, R., Seuwen, K. & Hoyer, D. (2000). Cloning, expression and pharmacological characterization of the mouse somatostatin sst5 receptor. Neuropharmacology 39, 1451–1462.

    Article  CAS  PubMed  Google Scholar 

  36. Foord, S.M. & Marshall, F.H. (1999). RAMPs: accessory proteins for seven transmembrane domain receptors. Trends Pharmacol.Sci. 20, 184–187.

    Article  CAS  PubMed  Google Scholar 

  37. Froidevaux, S. & Eberle, A.N. Somatostatin analogs and radiopeptides in cancer therapy. Biopolymers 66, 161–183 (2002).

    Article  CAS  PubMed  Google Scholar 

  38. Fukusumi, S., Kitada, C., Takekawa, S., Kizawa, H., Sakamoto, J., Miyamoto, M., Hinuma, S., Kitano, K. & Fujino, M. (1997). Identification and characterization of a novel human cortistatin-like peptide. Biochem.Biophys.Res.Commun. 232, 157–163.

    Article  CAS  PubMed  Google Scholar 

  39. Gademann, K., Kimmerlin, T, Hoyer, D. & Seebach, D. Peptide folding induces high and selective affinity of a linear and small 6-peptide to the human somatostatin receptor 4. J. Med. Chem. 44, 2460–2468 (2001).

    Article  CAS  PubMed  Google Scholar 

  40. Gu, Z.F., Corleto, V.D., Mantey, S.A., Coy, D.H., Maton, P.N. & Jensen, R.T. (1995). Somatostatin receptor subtype 3 mediates the inhibitory action of somatostatin on gastric smooth muscle cells. Am.J.Physiol. 268, G739–G748.

    CAS  PubMed  Google Scholar 

  41. Hocart, S.J., Jain, R., Murphy, W.A., Taylor, J.E. & Coy, D.H. (1999). Highly potent cyclic disulfide antagonists of somatostatin. J.Med.Chem. 42, 1863–1871.

    Article  CAS  PubMed  Google Scholar 

  42. Hofland, L.J., van der Hoek, J., Van Koetsveld, P.M., Bruns, C. Weckbecker, Mooij, D., Waaijers, M., van Aken, M., Beckers, A., de Herder, W.W. & Lamberts, S.W.J. The novel somatostatin analog SOM230 inhibits ACTH release by cultured human corticotroph tumors. Endocrine Soc. Meeting, Abstract P2-499 (June 2003).

    Google Scholar 

  43. Hoyer, D., Bell, G.I., Berelowitz, M., Epelbaum, J., Feniuk, W., Humphrey, P.P., O’Carroll, A.M., Patel, Y.C., Schonbrunn, A., Taylor, J.E. & Reisine, T. (1995a). Classification and nomenclature of somatostatin receptors. Trends.Pharmacol.Sci. 16, 86–88.

    Article  CAS  PubMed  Google Scholar 

  44. Hoyer, D., Dixon, K., Gentsch, C., Vassout, A., Enz, A., Jaton, A., Nunn, C., Schoeffter, P., Neumann, P., Troxler, T. & Pfaeffli, P. NVP-SRA880, a somatostatin sst 1 receptor antagonist promotes social interactions, reduces aggressive behaviour and stimulates learning. The Pharmacologist, 44, 2, suppl. 1, A254 (2002).

    Google Scholar 

  45. Hoyer, D., Epelbaum, J., Feniuk, W., Humphrey, P.P.A., Meyerhof, W., Patel, Y., Reisine, T., Reubi, J.C., Schonbrunn, A. & Vezzani, A. (2000), “Classification of somatostatin receptors”. In: The IUPHAR compendium of receptor characterisation and classification, IUPHAR Media.

    Google Scholar 

  46. Hoyer, D., Luebbert, H. & Bruns, C. (1994). Molecular pharmacology of somatostatin receptors. Naunyn-Schmiedeberg’s Arch.Pharmacol. 350, 441–453.

    CAS  Google Scholar 

  47. Hoyer, D., Perez, J., Schoeffter, P., Langenegger, D., Schuepbach, E., Kaupmann, K., Luebbert, H., Bruns, C. & Reubi, J.C. (1995b). Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors. Eur.J.Pharmacol, Mol.Pharmacol.Sect. 289, 151–161.

    CAS  Google Scholar 

  48. Kaupmann, K., Bruns, C., Raulf, F., Weber, H.P., Mattes, H. & Luebbert, H. (1995). Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201–995 for the SSTR2 somatostatin receptor. EMBO J. 14, 727–735.

    CAS  PubMed  Google Scholar 

  49. Kluxen, F.W., Bruns, C. & Luebbert, H. (1992). Expression cloning of a rat brain somatostatin receptor cDNA. Proc.Natl.Acad.Sci.U.S.A. 89, 4618–4622.

    CAS  PubMed  Google Scholar 

  50. Koenig, J.A., Edwardson, J.M. & Humphrey, P.P. (1997). Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br.J.Pharmacol. 120, 52–59.

    CAS  PubMed  Google Scholar 

  51. Krenning, E.P., Valkema, R., Kooij, P.P.M., Breeman, W.A.P., Bakker, W.H., De Herder, W.W., Van Eijck, C.H.J., Kwekkeboom, D.J., De Jong, M., Jamar, F. & Pauwels, S. (2000). The role of radioactive somatostatin and its analogues in the control of tumor growth. Recent Results Cancer Res. 153, 1–13.

    CAS  PubMed  Google Scholar 

  52. Lamberts, S.W., Van Der Lely, A.J., De Herder, W.W. & Hofland, L.J. (1996). Octreotide. N.EngJ.Med. 334, 246–254.

    CAS  Google Scholar 

  53. Lamberts, S.W.J., Krenning, E.P. & Reubi, J.C. (1991). The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr.Rev. 12, 450–482.

    CAS  PubMed  Google Scholar 

  54. Lanneau, C., Bluet-Pajot, M.T., Zizzari, P., Csaba, Z, Dournaud, P., Helboe, L., Hoyer, D., Pellegrini, E., Tannenbaum, G.S., Epelbaum, J. & Gardette, R. (2000). Involvement of the sst1 somatostatin receptor subtype in the intrahypothalamic neuronal network regulating growth hormone secretion: an in vitro and in vivo antisense study. Endocrinology 141, 967–979.

    Article  CAS  PubMed  Google Scholar 

  55. Lewis, I., Bauer, W., Albert, R., Chandramouli, N., Pless, J., Weckbecker, G. & Bruns, C. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J. Med. Chem. 46, 2334–2344 (2003).

    Article  CAS  PubMed  Google Scholar 

  56. Liapakis, G., Hoeger, C., Rivier, J. & Reisine, T. (1996). Development of a selective agonist at the somatostatin receptor subtype SSTR1. J.Pharmacol.Exp.Ther. 276, 1089–1094.

    CAS  PubMed  Google Scholar 

  57. Lichtenauer-Kaligis, E.G.R., Van Hagen, P.M., Lamberts, S.W.J. & Hofland, L.J. (2000). Somatostatin receptor subtypes in human immune cells. Eur.J.Endocrinol. 143, S21–S25.

    Article  CAS  PubMed  Google Scholar 

  58. Lloyd, K.C.K., Wang, J., Aurang, K., Gronhed, P., Coy, D.H. & Walsh, J.H. (1995). Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. Am.J.Physiol. 268, G102–G106.

    CAS  PubMed  Google Scholar 

  59. Mandarine, L., Stenner, D., Blanchard, W., Nissen, S., Gerich, J., Ling, N., Brazeau, P., Bohlen, P., Esch, F. & Guillemin, R. (1981). Selective effects of somatostatin-14,-25 and-28 on in vitro insulin and glucagon secretion. Nature 291, 76–77.

    Google Scholar 

  60. Marshall, F.H., Jones, K.A., Kaupmann, K. & Bettler, B. (1999). GABAB receptors-the first 7TM heterodimers. Trends Pharmacol.Sci. 20, 396–399.

    Article  CAS  PubMed  Google Scholar 

  61. Martin, J.L., Chesselet, M.F., Raynor, K., Gonzales, C. & Reisine, T. (1991). Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience (Oxford) 41, 581–593.

    CAS  Google Scholar 

  62. Martinez, V., Curi, A.P., Torkian, B., Schaeffer, J.M., Wilkinson, H.A., Walsh, J.H. & Tache, Y. (1998). High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. Gastroenterology 114, 1125–1132.

    Article  CAS  PubMed  Google Scholar 

  63. McHenry, L., Murthy, K.S., Grider, J.R. & Makhlouf, G.M. (1991). Inhibition of muscle cell relaxation by somatostatin: tissue-specific, cAMP-dependent, pertussis toxin-sensitive. AmJ.Physiol. 261, G45–G49.

    CAS  Google Scholar 

  64. McKeen, E.S., Feniuk, W., Michel, A.D., Kidd, E.J. & Humphrey, P.P.A. (1996). Identification and characterization of heterogeneous somatostatin binding sites in rat distal colonie mucosa. Naunyn-Schmiedeberg’s Arch.Pharmacol. 354, 543–549.

    CAS  Google Scholar 

  65. Meyerhof, W. (1998). The elucidation of somatostatin receptor functions: a current view. Rev.Physiol, Biochem. Pharmacol. 133, 55–105.

    CAS  Google Scholar 

  66. Meyerhof, W., Wulfsen, L, Schoenrock, C., Fehr, S. & Richter, D. (1992). Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain. Proc.Natl.Acad.Sci.U.S.A. 89, 10267–10271.

    CAS  PubMed  Google Scholar 

  67. Moldovan, S., DeMayo, F. & Brunicardi, F.C. (1998). Cloning of the mouse SSTR5 gene. J.Surg.Res. 76, 57–60.

    Article  CAS  PubMed  Google Scholar 

  68. Mundey, M.K., Ali, A., Mason, R. & Wilson, V.G. (2000). Pharmacological examination of contractile responses of the guinea-pig isolated ileum produced by μ-opioid receptor antagonists in the presence of, and following exposure to, morphine. Br.J.Pharmacol. 131, 893–902.

    Article  CAS  PubMed  Google Scholar 

  69. Nehring, R.B., Richter, D. & Meyerhof, W. (2000). Glycosylation affects agonist binding and signal transduction of the rat somatostatin receptor subtype 3. J.Physiol. (Paris) 94, 185–192.

    CAS  Google Scholar 

  70. Nunn, C. Rueping, M., Langenegger, D., Schuepbach, E., Kimmerlin, T., Micuh, P., Hurth, K., Seebach, D. & Hoyer, D. β2/β3-and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors. Ncmnyn Schmiedeberg’s Arch. Pharmacol. 367, 95–103 (2003a).

    CAS  Google Scholar 

  71. Nunn, C., Langenegger, D., Hurth, K., Fehlmann, D., Schmidt, K. & Hoyer, D. Agonist properties of putative small molecule somatostatin receptor subtype-2 selective antagonists. Eur. J. Pharmacol., 465, 211–218 (2003c).

    Article  CAS  PubMed  Google Scholar 

  72. Nunn, C., Schoeffter, P., Langenegger, D. & Hoyer, D. Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806. Naunyn Schmiedeberg’s Arch Pharmacol. 367, 1–9 (2003b).

    CAS  Google Scholar 

  73. O’Carroll, A.M., Lolait, S.J., Koenig, M. & Mahan, L.C. (1992). Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28. Mol.Pharmacol. 42, 939–946.

    CAS  PubMed  Google Scholar 

  74. Oomen, S.P.M.A., Hofland, L.J., Van Hagen, P.M., Lamberts, S.W.J. & Touw, I.P. (2000). Somatostatin receptors in the haematopoietic system. Eur.J.Endocrinol. 143, S9–S14.

    Article  CAS  PubMed  Google Scholar 

  75. Panetta, R., Greenwood, M.T., Warszynska, A., Demchyshyn, L.L., Day, R., Niznik, H.B., Srikant, C.B. & Patel, Y.C. (1994). Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol.Pharmacol. 45, 417–427.

    CAS  PubMed  Google Scholar 

  76. Parmar, R.M., Chan, W.W., Dashkevicz, M., Hayes, E.C., Rohrer, S.P., Smith, R.G., Schaeffer, J.M. & Blake, A.D. (1999). Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells. Biochem.Biophys.Res.Commun. 263, 276–280.

    Article  CAS  PubMed  Google Scholar 

  77. Patel, Y.C. & Galanopoulou, A. (1995). Processing and intracellular targeting of prosomatostatin-derived peptides: the role of mammalian endoproteases. Ciba Found.Symp. 190, 26–50.

    CAS  PubMed  Google Scholar 

  78. Patel, Y.C. & O’Neil, W. (1988). Peptides derived from cleavage of prosomatostatin at carboxyl-and amino-terminal segments. Characterization of tissue and secreted forms in the rat. J.Biol.Chem. 263,745–751.

    CAS  PubMed  Google Scholar 

  79. Patel, Y.C. & Srikant, C.B. (1994). Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1–5). Endocrinology 135, 2814–2817.

    Article  CAS  PubMed  Google Scholar 

  80. Patel, Y.C. & Srikant, C.B. (1997). Somatostatin receptors. Trends Endocrinol.Metab. 8, 398–405.

    CAS  Google Scholar 

  81. Patel, Y.C. (1997). Molecular pharmacology of somatostatin receptor subtypes. J.Endocrinol.Invest. 20, 348–367.

    CAS  PubMed  Google Scholar 

  82. Patel, Y.C. (1999). Somatostatin and its receptor family. Front.Neuroendocrinol. 20, 157–198.

    CAS  PubMed  Google Scholar 

  83. Patel, Y.C., Greenwood, M., Kent, G., Panetta, R. & Srikant, C.B. (1993). Multiple gene transcripts of the somatostatin receptor SSTR2: Tissue selective distribution and cAMP regulation. Biochem.Biophys.Res.Commun. 192, 288–294.

    Article  CAS  PubMed  Google Scholar 

  84. Pfeiffer, M., Koch, T., Schroder, H., Klutzny, M., Kirscht, S., Kreienkamp, HJ., Hollt, V., Schulz, S., Homo-and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J. Biol. Chem. 276: 14027–14036 (2001).

    Article  CAS  PubMed  Google Scholar 

  85. Pfeiffer, M., Koch, T., Schroder, H., Laugsch, M., Hollt, V. & Schulz S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J. Biol. Chem. 277, 19762–19772 (2002).

    Article  CAS  PubMed  Google Scholar 

  86. Piwko, C., Thoss, V.S. & Hoyer, D. (1995). Localization and pharmacological characterization of somatostatin sst2 sites in the rat cerebellum. Naunyn-Schmiedeberg’s Arch Pharmacol. 352, 607–613.

    CAS  Google Scholar 

  87. Piwko, C., Thoss, V.S., Probst, A. & Hoyer, D. (1996). Localization and pharmacological characterization of somatostatin recognition sites in human cerebellum. Neuropharmacology 35, 713–723.

    Article  CAS  PubMed  Google Scholar 

  88. Piwko, C., Thoss, V.S., Probst, A. & Hoyer, D. (1997). The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum. J Recept.Signal Transduction Res. 17, 385–105.

    CAS  Google Scholar 

  89. Poitout, L., Roubert, P., Contour-Galcera, M.-O., Moinet, C., Lannoy, J., Pommier, J., Plas, P., Bigg, D. & Thurieau, C. Identification of potent non-peptide somatostatin antagonists with ss3 selectivity. J. Med. Chem. 44, 2990–3000 (2001).

    Article  CAS  PubMed  Google Scholar 

  90. Pradayrol, L., Jornvall, H., Mutt, V. & Ribet, A. (1980). N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett. 109, 55–58.

    Article  CAS  PubMed  Google Scholar 

  91. Prinz, C., Sachs, G., Walsh, J.H., Coy, D.H. & Wu, S.V. (1994). The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology 107, 1067–1074.

    CAS  PubMed  Google Scholar 

  92. Puebla, L., Mouchantaf, R., Sasi, R., Khare, S., Bennett, H.P.J., James, S. & Patel, Y.C. (1999). Processing of rat preprocortistatin in mouse AtT-20 cells. J.Neurochem. 73, 1273–1277.

    Article  CAS  PubMed  Google Scholar 

  93. Raynor, K. & Reisine, T. (1992). Somatostatin receptors. Crit.Rev.Neurobiol. 6, 273–289.

    CAS  PubMed  Google Scholar 

  94. Raynor, K., Coy, D.C. & Reisine, T. (1992). Analogs of somatostatin bind selectively to brain somatostatin receptor subtypes. J.Neurochem. 59, 1241–1250.

    CAS  PubMed  Google Scholar 

  95. Raynor, K., Murphy, W.A., Coy, D.H., Taylor, J.E., Moerau, J.P., Yasuda, K., Bell, G.I. & Reisine, T. (1993a). Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol.Pharmacol. 43, 838–844.

    CAS  PubMed  Google Scholar 

  96. Raynor, K., O’Carroll, A.M., Kong, H., Yasuda, K., Mahana, L.C., Bell, G.I. & Reisine, T. (1993b). Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol.Pharmacol. 44, 385–392.

    CAS  PubMed  Google Scholar 

  97. Reichlin, S. (1983). Somatostatin. N.Engl.J.Med 309, 1556–1563.

    CAS  PubMed  Google Scholar 

  98. Reisine, T. & Bell, G.I. (1995). Molecular biology of somatostatin receptors. Endocr.Rev. 16, 427–442.

    Article  CAS  PubMed  Google Scholar 

  99. Reubi, J.C. & Maurer, R. (1986). Different ionic requirements for somatostatin receptor subpopulations in the brain. Regul.Pept. 14, 301–311.

    Article  CAS  PubMed  Google Scholar 

  100. Reubi, J.C. (1984). Evidence for two somatostatin-14 receptor types in rat brain cortex. Neurosc.Lett. 49, 259–263.

    CAS  Google Scholar 

  101. Reubi, J.C., Schaer, J.C., Waser, B., Hoeger, C. & Rivier, J. (1998). A selective analog for the somatostatin sst1-receptor subtype expressed by human tumors. Eur.J.Pharmacol. 345,103–110.

    Article  CAS  PubMed  Google Scholar 

  102. Reubi, J.C., Schaer, J.C., Wenger, S., Hoeger, C., Erchegyi, J., Waser, B. & Rivier, J. SST3-selective potent peptidic somatostatin receptor antagonists. Proc. Natl. Acad. Sci. U.S.A. 97, 13973–13978 (2000).

    Article  CAS  PubMed  Google Scholar 

  103. Reubi, J:C., Eisenwiener, K.-P., Rink, H., Waser, B., & Macke, H.R. A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. Eur. J. Pharmacol. 456, 45–49 (2002).

    Article  CAS  PubMed  Google Scholar 

  104. Rocheville, M., Lange, D.C., Kumar, U., Patel, S.C., Patel, R.C. & Patel, Y.C. (2000a). Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science (Washington, D.C.) 288, 154–157.

    CAS  Google Scholar 

  105. Rocheville, M., Lange, D.C., Kumar, U., Sasi, R., Patel, R.C. & Patel, Y.C. (2000b). Subtypes of the somatostatin receptor assemble as functional homo-and heterodimers. J.Biol.Chem. 275, 7862–7869.

    Article  CAS  PubMed  Google Scholar 

  106. Rohrer, L., Raulf, F., Brans, C., Buettner, R., Hofstaedter, F. & Schuele, R. (1993). Cloning and characterization of a fourth human somatostatin receptor. Proc.Natl.Acad.Sci.U.S.A. 90, 4196–4200.

    CAS  PubMed  Google Scholar 

  107. Rohrer, S.P. & Berk, S.C. (1999). Development of somatostatin receptor subtype selective agonists through combinatorial chemistry. Curr.Opin.Drug Discovery Dev. 2, 293–303.

    CAS  Google Scholar 

  108. Rohrer, S.P. & Schaeffer, J.M. (2000). Identification and characterization of subtype selective somatostatin receptor agonists. J.Physiol. (Paris) 94, 211–215.

    CAS  Google Scholar 

  109. Rohrer, S.P., Birzin, E.T., Mosley, R.T., Berk, S.C., Hutchins, S.M., Shen, D.M., Xiong, Y., Hayes, E.C., Parmar, R.M., Poor, F., Mitra, S.W., Degrade, S.J., Shu, M., Klopp, J.M., Cai, S.J., Blake, A., Chan, W.W.S., Pasternak, A., Yang, L., Patchett, A.A., Smith, R.G., Chapman, K.T. & Schaeffer, J.M. (1998). Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science (Washington, D.C.) 282, 737–740.

    CAS  Google Scholar 

  110. Rossowski, W.J. & Coy, D.H. (1994). Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. Biochem.Biophys.Res.Commun. 205, 341–346.

    Article  CAS  PubMed  Google Scholar 

  111. Rossowski, W.J., Gu, Z.F., Akarca, U.S., Jensen, R.T. & Coy, D.H. (1994). Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release. Peptides (Tarrytown, N.Y.) 15, 1421–1424.

    CAS  Google Scholar 

  112. Schindler, M., Harrington, K.A., Humphrey, P.P.A. & Emson, P.C. (1995). Cellular localization and co-expression of somatostatin receptor messenger RNAs in the human brain. Mol.Brain Res. 34, 321–326.

    Article  CAS  PubMed  Google Scholar 

  113. Schloos, J., Raulf, F., Hoyer, D. & Bruns, C. (1997). Identification and pharmacological characterization of somatostatin receptors in rat lung. Br.J.Pharmacol. 121, 963–971.

    CAS  PubMed  Google Scholar 

  114. Schoeffter, P., Perez, J., Langenegger, D., Schuepbach, E., Bobirnac, I., Luebbert, H., Brans, C. & Hoyer, D. (1995). Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors. Eur. J. Pharmacoi, Mol. Pharmacol. Sect. 289, 163–173.

    CAS  Google Scholar 

  115. Schwabe, W., Brennan, M.B. & Hochgeschwender, U. (1996). Isolation and characterization of the mouse (Mus musculus) somatostatin receptor type-4-encoding gene (mSSTR4). Gene 168, 233–235.

    Article  CAS  PubMed  Google Scholar 

  116. Seebach, D., Schaeffer, L., Brenner, M. & Hoyer, D. Design and synthesis of □-dipeptide derivatives with submicromolar affinities for human somatostatin receptors. Angew. Chemie, Int. Ed. 42, 776–778 (2003).

    CAS  Google Scholar 

  117. Sellers, L.A., Alderton, F., Carruthers, A.M., Schindler, M. & Humphrey, P.P.A. (2000). Receptor isoforms mediate opposing proliferative effects through Gβγ-activated p38 or Akt pathways. Mol. Cell. Biol. 20, 5974–5985.

    Article  CAS  PubMed  Google Scholar 

  118. Seimer, I-S., Schindler, M., Allen, J. P., Humphrey, P. P. A. & Emson, P. C. Advances in understanding neuronal somatostatin receptors. Reg. Pep. 90, 1–18 (2000).

    Google Scholar 

  119. Sharma, K. & Srikant, C.B. (1998). Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells. Int. J. Cancer 76, 259–266.

    Article  CAS  PubMed  Google Scholar 

  120. Shimon, I., Taylor, J.E., Dong, J.Z., Bitonte, R.A., Kim, S., Morgan, B., Coy, D.H., Culler, M.D. & Melmed, S. (1997a). Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J.Clin.Invest. 99, 789–798.

    CAS  PubMed  Google Scholar 

  121. Shimon, I., Yan, X., Taylor, J.E., Weiss, M.H., Culler, M.D. & Melmed, S. (1997b). Somatostatin receptor (SSTR) subtype-selective analogs differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas: novel potential therapy for functional pituitary tumors. J.Clin.Invest. 100, 2386–2392.

    CAS  PubMed  Google Scholar 

  122. Siehler, S. & Hoyer, D. (1999a). Characterization of human recombinant somatostatin receptors. 2. Modulation of GTP.gamma.S binding. Naunyn-Schmiedeberg’s Arch.Pharmacol. 360, 500–509.

    CAS  Google Scholar 

  123. Siehler, S. & Hoyer, D. (1999b). Characterization of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity. Naunyn-Schmiedeberg’s Arch.Pharmacol. 360, 510–521.

    CAS  Google Scholar 

  124. Siehler, S. & Hoyer, D. (1999c). Characterization of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity. Naunyn-Schmiedeberg’s Arch.Pharmacol. 360, 522–532.

    CAS  Google Scholar 

  125. Siehler, S., Seuwen, K. & Hoyer, D. (1998a). [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. Eur.J.Pharmacol. 348, 311–320.

    Article  CAS  PubMed  Google Scholar 

  126. Siehler, S., Seuwen, K. & Hoyer, D. (1998b). [125I]TyrlO-cortistatinl4 labels all five somatostatin receptors. Naunyn-Schmiedeberg’s Arch.Pharmacol. 357, 483–489.

    CAS  Google Scholar 

  127. Siehler, S., Seuwen, K. & Hoyer, D. (1999a). Characterization of human recombinant somatostatin receptors. 1. Radioligand binding studies. Naunyn-Schmiedeberg’s Arch.Pharmacol. 360, 488–499.

    CAS  Google Scholar 

  128. Siehler, S., Zupanc, G.K.H., Seuwen, K. & Hoyer, D. (1999b). Characterization of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features. Neuropharmacology 38, 449–462.

    Article  CAS  PubMed  Google Scholar 

  129. Spier, A.D. & De Lecea, L. (2000). Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res.Rev. 33, 228–241.

    Article  CAS  PubMed  Google Scholar 

  130. Stolz, B., Weckbecker, G., Smith-Jones, P.M., Albert, R., Raulf, F. & Bruns, C. (1998). The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-dPhel,Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumors. Eur. J. Nucl. Med. 25, 668–674.

    Article  CAS  PubMed  Google Scholar 

  131. Strowski, M.Z., Parmar, R.M., Blake, A.D. & Schaeffer, J.M. (2000). Somatostatin inhibits insulin and glucagon secretion via two receptor subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 141, 111–117.

    Article  CAS  PubMed  Google Scholar 

  132. Thoss, V.S., Perez, J., Due, D. & Hoyer, D. (1995). Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain. Neuropharmacology 34, 1673–1688.

    Article  CAS  PubMed  Google Scholar 

  133. Thoss, V.S., Piwko, C. & Hoyer, D. (1996). Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization. Naunyn-Schmiedeberg’s Arch.Pharmacol. 353, 648–660.

    CAS  Google Scholar 

  134. Thoss, V.S., Piwko, C., Probst, A. & Hoyer, D. (1997). Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary. Naunyn-Schmiedeberg’s Arch. Pharmacol. 355, 168–176.

    CAS  Google Scholar 

  135. Tilakaratne, N., Christopoulos, G., Zumpe, E.T., Foord, S.M. & Sexton, P.M. (2000). Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. J. Pharmacol. Exp. Ther. 294, 61–72.

    CAS  PubMed  Google Scholar 

  136. Tran, V.T., Beal, M.F. & Martin, J.B. (1985). Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science (Washington, D.C., 1883-) 228, 492–495.

    CAS  Google Scholar 

  137. Vale, W., Rivier, C., Brazeau, P. & Guillemin, R. (1974). Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology 95, 968–977.

    CAS  PubMed  Google Scholar 

  138. Vanetti, M., Kouba, M., Wang, X., Vogt, G. & Hoellt, V. (1992). Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 311, 290–294.

    Article  CAS  PubMed  Google Scholar 

  139. Warhurst, G., Higgs, N.B., Fakhoury, H., Warhurst, A.C., Garde, J. & Coy, D.H. (1996). Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon. Gastroenterologe 111, 325–333.

    CAS  Google Scholar 

  140. Weckbecker, G., Briner, U., Lewis, I. & Bruns, C. SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone/insulin-like growth factor-I axis in rats, primates, and dogs. Endocrinology 143, 4123–4130 (2002).

    Article  CAS  PubMed  Google Scholar 

  141. Weckbecker, G., Raulf, F., Tolesvai, L. & Bruns, C. (1996). Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo. Digestion 57, 22–28.

    CAS  PubMed  Google Scholar 

  142. Weckbecker, G., Stolz, B., Susini, C. & Bruns, C. (1999), “Antiproliferative somatostatin analogues with potential in oncology”. In: Octreotide, the next decade. St. Lamberts, ed. BioScientifica Bristol, pp. 339–352.

    Google Scholar 

  143. White, J.H., Wise, A., Main, M.J., Green, A., Fraser, N.J., Disney, G.H., Barnes, A.A., Emson, P., Foord, S.M. & Marshall, F.H. (1998). Heterodimerization is required for the formation of a functional GABAB receptor. Nature 396, 679–682.

    CAS  PubMed  Google Scholar 

  144. Wilkinson, G.F., Feniuk, W. & Humphrey, P.P. (1997). Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism. BrJ.Pharmacol. 121, 91–96.

    CAS  Google Scholar 

  145. Xu, Y., Song, J., Bruno, J.F. & Berelowitz, M. (1993). Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4. Biochem.Biophys.Res.Commun. 193, 648–652.

    CAS  PubMed  Google Scholar 

  146. Yamada, Y., Kagimoto, S., Kubota, A., Yasuda, K., Masuda, K., Someya, Y., Ihara, Y., Li, Q. & Imura, H. (1993a). Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTRS) human somatostatin receptor subtype. Biochem.Biophys.Res.Commun. 195, 844–852.

    CAS  PubMed  Google Scholar 

  147. Yamada, Y., Post, S.R., Wang, K., Tager, H.S., Bell, G.I. & Seino, S. (1992a). Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. U.S.A. 89; 251–255.

    CAS  PubMed  Google Scholar 

  148. Yamada, Y., Reisine, T., Law, S.F., Ihara, Y., Kubota, A., Kagimoto, S., Seino, M., Seino, Y., Bell, G.I. & Seino, S. (1992b). Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol. Endocrinol. 6, 2136–2142.

    Article  CAS  PubMed  Google Scholar 

  149. Yamada, Y., Stoffel, M., Espinosa, R.E. III, Xiang, K.S., Seino, M., Seino, S., Le Beau, M.M. & Bell, G.I. (1993b). Human somatostatin receptor genes: Localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms. Genomics 15, 449–452.

    Article  CAS  PubMed  Google Scholar 

  150. Yang, L., Berk, S.C., Rohrer, S.P. Mosley, R.T., Guo, L., Underwood, D.J., Arison, B.H., Birzin, E.T., Hayes, E.C., Mitra, S.W., Parmar, R.M., Cheng, K., Wu, T.J., Butler, B.S., Poor, F., Pasternak, A., Pan, Y., Silva, M., Freidinger, R.M., Smith, R.G., Chapman, K., Schaeffer, J.M. & Patchett, A.A. (1998). Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc. Natl. Acad. Sci. U.S.A. 95, 10836–10841.

    CAS  PubMed  Google Scholar 

  151. Yasuda, K., Rens-Domiano, S., Breder, C.D., Law, S.F., Saper, C.B., Reisine, T. & Bell, G.I. (1992). Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylyl cyclase. J. Biol. Chem. 267, 20422–20428.

    CAS  PubMed  Google Scholar 

  152. Zaki, M., Harrington, L., McCuen, R., Coy, D.H., Arimura, A. & Schubert, M.L. (1996). Somatostatin receptor subtype 2 mediates inhibition of gastrin and histamine secretion from human, dog, and rat antrum. Gastroenterology 111, 919–924.

    Article  CAS  PubMed  Google Scholar 

  153. Zheng, H., Bailey, A., Jiang, M.H., Honda, K., Chen, H.Y., Trumbauer, M.E., Van der Ploeg, L.H., Schaeffer, J.M., Leng, G. & Smith, R.G. (1997). Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol. Endocrinol. 11, 1709–1717.

    Article  CAS  PubMed  Google Scholar 

  154. Zumpe, E.T., Tilakaratne, N., Fraser, N.J., Christopoulos, G., Foord, S.M. & Sexton, P.M. (2000). Multiple Ramp Domains Are Required for Generation of Amylin Receptor Phenotype from the Calcitonin Receptor Gene Product. Biochem. Biophys. Res. Commun. 267, 368–372.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroscience and Transplantation Research, Novartis Institutes for Biomedical Research, CH-4002, Basel, Switzerland

    Jason P. Hannon & Daniel Hoyer

Authors
  1. Jason P. Hannon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christian Bruns
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gisbert Weckbecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Hoyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, McGill University Heath Center, Montréal, Québec, Canada

    Coimbatore B. Srikant

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science + Business Media, Inc.

About this chapter

Cite this chapter

Hannon, J.P., Bruns, C., Weckbecker, G., Hoyer, D. (2004). Somatostatin Receptor Gene Family - Subtype Selectivity for Ligand Binding. In: Srikant, C.B. (eds) Somatostatin. Endocrine Updates, vol 24. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8033-6_6

Download citation

  • DOI: https://doi.org/10.1007/1-4020-8033-6_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7799-9

  • Online ISBN: 978-1-4020-8033-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation